If I was a betting man, I'd say this is the week. AGN timeline for ethics submission, approval, and first patient dosed are centered on the timeline highlights that it can be done.
Dates and additional clinical programs are speculative, but align with management strategy for rapidly maximising value of Bisantrene and combination preclinical studies completed to date.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.005(0.41%) |
Mkt cap ! $212.8M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.26 | $1.22 | $67.00K | 53.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2078 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 10000 | 1 |
View Market Depth
| Last trade - 15.11pm 25/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |